RADICAVA

This brand name is authorized in Canada, United States

Active ingredients

The drug RADICAVA contains one active pharmaceutical ingredient (API):

1 Edaravone UNII S798V6YJRP - EDARAVONE

Edaravone is a member of the substituted 2-pyrazolin-5-one class. It is used for the treatment of amyotrophic lateral sclerosis (ALS). The mechanism by which edaravone exerts its therapeutic effect in patients with ALS is unknown. Read about Edaravone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RADICAVA Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX14		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02475472
Country: US	FDA, National Drug Code	Identifier(s): 70510-2171